Atorvastatin in Relapsing-Remitting Multiple Sclerosis

This study has been completed.

Study NCT00616187 Information provided by Charite University, Berlin, Germany

First Received: February 5, 2008 Last Updated: February 14, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)

No publications provided by Charite University, Berlin, Germany

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Paul F, Waiczies S, Wuerfel J, Bellmann-Strobl J, Dörr J, Waiczies H, Haertle M, Wernecke KD, Volk HD, Aktas O, Zipp F. Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PLoS ONE. 2008 Apr 9;3(4):e1928.